Inhibrx Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Inhibrx Biosciences, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 3, 2026, to elect directors and ratify the appointment of its independent auditor.
NASDAQ
Inhibrx Biosciences, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Inhibrx Biosciences announces its 2025 Annual Meeting of Stockholders to be held virtually on May 28, 2025, to elect directors and ratify the appointment of its independent accounting firm.